CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Clinical trials for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE trials appear
Sign up with your email to follow new studies for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients Who've run out of options
Disease control Recruiting nowThis early-stage study tests a new drug called ELVN-001 in people with chronic myeloid leukemia (CML) whose cancer has not responded to or who cannot tolerate other treatments. The main goals are to check the drug's safety and find the best dose. About 250 adults with CML will ta…
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: Enliven Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New vaccine aims to shield stem cell patients from dangerous virus
Prevention Recruiting nowThis early-phase trial tests a vaccine (CMV-MVA Triplex) given to both stem cell donors and recipients to boost immunity against cytomegalovirus (CMV) and prevent active infection after a half-matched stem cell transplant. About 46 people with various blood cancers will take part…
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Jul 02, 2026 02:00 UTC